PLX:NYSEAMERICAN
Protalix Biotherapeutics Inc
$2.73
arrow_upward
+0.74%(+0.020) 1D
$2.73
arrow_downward
-0.07% (-0.0018)bedtimeAfter hours
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLX...
Open
$2.74
High
$2.76
Low
$2.65
Mkt. cap
219.96M
Avg. vol.
777.52K
Volume
934.74K
P/E ratio
12.07
52-wk high
$3.19
52-wk low
$1.60
EPS
$0.23
Beta
-0.09
Shares outstanding
80.57M
No. of employees
226
Open
$2.74
High
$2.76
Low
$2.65
Mkt. cap
219.96M
Avg. vol.
777.52K
Volume
934.74K
P/E ratio
12.07
52-wk high
$3.19
52-wk low
$1.60
EPS
$0.23
Beta
-0.09
Shares outstanding
80.57M
No. of employees
226
News stories
From web sources and news partners
富途牛牛
·
5 minutes ago
The S&P 500 hit a record high, but gains were driven almost exclusively by AI-related stocks.
Simply Wall Street
·
37 minutes ago
How $950 Million Settlement Will Impact Roivant Sciences Stock (ROIV)
VT Markets
·
14 minutes ago
S&P 500 futures test 7,800 as AI rally persists amid bearish retail sentiment and macro headwinds
Profile
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
About Protalix Biotherapeutics Inc
CEODror Bashan
Employees226
Founded1993
HeadquartersKarmiel, North District, Israel
SectorBiotechnology
Websiteprotalix.com